Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. The Lancet infectious diseases 16 (5), 565-575, 2016 | 299 | 2016 |
How the weather affects the pain of citizen scientists using a smartphone app WG Dixon, AL Beukenhorst, BB Yimer, L Cook, A Gasparrini, T El-Hay, ... NPJ digital medicine 2 (1), 105, 2019 | 69 | 2019 |
Gibbs sampling in factorized continuous-time Markov processes T El-Hay, N Friedman, R Kupferman arXiv preprint arXiv:1206.3251, 2012 | 58 | 2012 |
Mean field variational approximation for continuous-time Bayesian networks I Cohn, T El-Hay, N Friedman, R Kupferman The Journal of Machine Learning Research 11, 2745-2783, 2010 | 54 | 2010 |
Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics KA Cohen, T El-Hay, KL Wyres, O Weissbrod, V Munsamy, C Yanover, ... EBioMedicine 9, 170-179, 2016 | 52 | 2016 |
Mean field variational approximation for continuous-time Bayesian networks I Cohn, T El-Hay, N Friedman, R Kupferman arXiv preprint arXiv:1205.2655, 2012 | 37 | 2012 |
Continuous-Time Belief Propagation. T El-Hay, I Cohn, N Friedman, R Kupferman ICML, 343-350, 2010 | 31 | 2010 |
Adversarial balancing for causal inference M Ozery-Flato, P Thodoroff, M Ninio, M Rosen-Zvi, T El-Hay arXiv preprint arXiv:1810.07406, 2018 | 30 | 2018 |
Continuous time markov networks T El-Hay, N Friedman, D Koller, R Kupferman arXiv preprint arXiv:1206.6838, 2012 | 25 | 2012 |
Integrated multisystem analysis in a mental health and criminal justice ecosystem E Falconer, T El-Hay, D Alevras, JP Docherty, C Yanover, A Kalton, ... Health & Justice 5, 1-8, 2017 | 18 | 2017 |
Progress in characterizing the human exposome: a key step for precision medicine F Martin-Sanchez, R Bellazzi, V Casella, W Dixon, G Lopez-Campos, ... Yearbook of medical informatics 29 (01), 115-120, 2020 | 15 | 2020 |
Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome M Ozery-Flato, N Parush, T El-Hay, Ž Visockienė, L Ryliškytė, J Badarienė, ... Diabetology & metabolic syndrome 5, 1-9, 2013 | 15 | 2013 |
Dynamic ranges for viterbi calculations I Bartur, A Globerson, T El-Hay, T Yadid US Patent App. 10/650,040, 2005 | 11 | 2005 |
Incorporating expressive graphical models in variational approximations: Chain-graphs and hidden variables T El-Hay, N Friedman arXiv preprint arXiv:1301.2268, 2013 | 10 | 2013 |
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature R Wyss, C Yanover, T El‐Hay, D Bennett, RW Platt, AR Zullo, G Sari, ... Pharmacoepidemiology and drug safety 31 (9), 932-943, 2022 | 9 | 2022 |
Paradoxical hypersusceptibility of drug-resistant Mycobacterium tuberculosis to β-lactam antibiotics. EBioMedicine 9: 170–179 KA Cohen, T El-Hay, KL Wyres, O Weissbrod, V Munsamy, C Yanover, ... | 8 | 2016 |
How the weather affects the pain of citizen scientists using a smartphone app. npj Digit. Med. 2, 105 WG Dixon, AL Beukenhorst, BB Yimer, L Cook, A Gasparrini, T El-Hay, ... | 7 | 2019 |
Towards global model generalizability: independent cross-site feature evaluation for patient-level risk prediction models using the OHDSI network B Naderalvojoud, CM Curtin, C Yanover, T El-Hay, B Choi, RW Park, ... Journal of the American Medical Informatics Association 31 (5), 1051-1061, 2024 | 4 | 2024 |
Characterizing subpopulations by exposure response RY Aharonov, T El-Hay, M Flato, Y Goldschmidt, NP Shear-Yashuv, ... US Patent App. 14/953,514, 2017 | 4 | 2017 |
Usage of quantitative information gain to support decisions in sequential clinical risk assessment examinations T El-Hay, M Flato, N Parush-Shear-Yashuv US Patent 9,189,764, 2015 | 4 | 2015 |